IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 24 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,631,550,000 | -1.9% | 1,285,000 | 0.0% | 3.00% | +0.1% |
| Q4 2021 | $12,875,700,000 | +0.2% | 1,285,000 | 0.0% | 3.00% | -6.0% |
| Q3 2021 | $12,850,000,000 | -0.5% | 1,285,000 | 0.0% | 3.18% | +5.9% |
| Q2 2021 | $12,914,250,000 | +1.9% | 1,285,000 | 0.0% | 3.01% | +37.5% |
| Q1 2021 | $12,670,100,000 | – | 1,285,000 | – | 2.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |